Ménière's disease

Lloyd B. Minor, David A. Schessel, John P. Carey

Research output: Contribution to journalReview articlepeer-review

148 Scopus citations


Purpose of review: Ménière's disease is characterized by spontaneous attacks of vertigo, fluctuating sensorineural hearing loss, aural fullness, and tinnitus. The pathologic process involves distortion of the membranous labyrinth with the formation of endolymphatic hydrops. This review describes the pathogenesis and etiology as wall as the diagnosis and treatment of Ménière's disease. Recent findings: Initial management of Ménière's disease can involve a low-salt diet and a diuretic. Treatment with intratympanic injection of gentamicin can be beneficial when vertigo persists despite optimal medical management. Recent studies have shown that gentamicin reduces vestibular function in the treated ear, although complete ablation of this vestibular function is not typically required in order to achieve control of vertigo. Summary: Vertigo is often the most debilitating symptom associated with Ménière's disease. Many treatment options exist for the management of vertigo. Intratympanic injection of gentamicin (low dose) can be used in patients for whom vertigo has not been controlled by medical measures. Ongoing research is providing a greater understanding of the effects of gentamicin on vestibular function and of the mechanisms through which gentamicin leads to control of vertigo.

Original languageEnglish (US)
Pages (from-to)9-16
Number of pages8
JournalCurrent opinion in neurology
Issue number1
StatePublished - Feb 2004


  • Endolymphatic hydrops
  • Gentamicin
  • Hearing loss
  • Ménière's disease
  • Tinnitus
  • Vertigo
  • Vestibular evoked myogenic potential
  • Vestibulo-ocular reflex

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Ménière's disease'. Together they form a unique fingerprint.

Cite this